BRUCHMANN Group (family of Dietrich Bruchmann)

	Start	2023-02-27 existent
	Industry	investment management
	Industry 2	MedTech (medical technology)
	Person	Bruchmann, Dietrich (Nuvisan 2022 Managing Director of Nuvisan Pharma Holding GmbH)

	Region	Neu-Ulm
	Country	Germany
	City	n. a.
		Address record changed: 2023-03-17

Basic data	Employees	n. a.


		Record changed: 2023-12-30

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

More documents for BRUCHMANN Group (family of Dietrich Bruchmann)

[1] TolerogenixX GmbH. (7/6/23). "Press Release: TolerogenixX Expands Phase II Immune-tolerance Trial and Closes EUR 12 million Series A Financing"....
[2] VisionHealth GmbH. (2/27/23). "Press Release: VisionHealth Raises 3 Million Euro to Finance Extended COPD and Asthma Study for Market Preparation of Kata, an Innovative Digital Therapeutic for Improved Inhalation". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)